Class II
Terminated
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Ci…
Why: Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
- Company
- Cipla USA, Inc.
Warren, NJ, United States - Reported
- May 1, 2024
- Recall started
- Mar 26, 2024
- Ended
- Jul 9, 2025
- Where sold
- USA nationwide.
- Amount
- 59244/3ml FFS packs
- Full product description
- Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53
- Lots / codes affected
- Lot # IA30390, Exp 4/30/2025, IA30517, Exp 6/30/ 2025
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.